Cargando…

Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome

BACKGROUND: Adults with Down syndrome (DS) are at increased risk for Alzheimer disease dementia, and there is a pressing need for the development of assessment instruments that differentiate chronic cognitive impairment, acute neuropsychiatric symptomatology, and dementia in this population of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessov-Schlaggar, Christina N., del Rosario, Olga L., Morris, John C., Ances, Beau M., Schlaggar, Bradley L., Constantino, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912998/
https://www.ncbi.nlm.nih.gov/pubmed/31842726
http://dx.doi.org/10.1186/s11689-019-9300-2
_version_ 1783479585593098240
author Lessov-Schlaggar, Christina N.
del Rosario, Olga L.
Morris, John C.
Ances, Beau M.
Schlaggar, Bradley L.
Constantino, John N.
author_facet Lessov-Schlaggar, Christina N.
del Rosario, Olga L.
Morris, John C.
Ances, Beau M.
Schlaggar, Bradley L.
Constantino, John N.
author_sort Lessov-Schlaggar, Christina N.
collection PubMed
description BACKGROUND: Adults with Down syndrome (DS) are at increased risk for Alzheimer disease dementia, and there is a pressing need for the development of assessment instruments that differentiate chronic cognitive impairment, acute neuropsychiatric symptomatology, and dementia in this population of patients. METHODS: We adapted a widely used instrument, the Clinical Dementia Rating (CDR) Scale, which is a component of the Uniform Data Set used by all federally funded Alzheimer Disease Centers for use in adults with DS, and tested the instrument among 34 DS patients recruited from the community. The participants were assessed using two versions of the modified CDR—a caregiver questionnaire and an in-person interview involving both the caregiver and the DS adult. Assessment also included the Dementia Scale for Down Syndrome (DSDS) and the Raven’s Progressive Matrices to estimate IQ. RESULTS: Both modified questionnaire and interview instruments captured a range of cognitive impairments, a majority of which were found to be chronic when accounting for premorbid function. Two individuals in the sample were strongly suspected to have early dementia, both of whom had elevated scores on the modified CDR instruments. Among individuals rated as having no dementia based on the DSDS, about half showed subthreshold impairments on the modified CDR instruments; there was substantial agreement between caregiver questionnaire screening and in-person interview of caregivers and DS adults. CONCLUSIONS: The modified questionnaire and interview instruments capture a range of impairment in DS adults, including subthreshold symptomatology, and the instruments provide complementary information relevant to the ascertainment of dementia in DS. Decline was seen across all cognitive domains and was generally positively related to age and negatively related to IQ. Most importantly, adjusting instrument scores for chronic, premorbid impairment drastically shifted the distribution toward lower (no impairment) scores.
format Online
Article
Text
id pubmed-6912998
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69129982019-12-30 Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome Lessov-Schlaggar, Christina N. del Rosario, Olga L. Morris, John C. Ances, Beau M. Schlaggar, Bradley L. Constantino, John N. J Neurodev Disord Research BACKGROUND: Adults with Down syndrome (DS) are at increased risk for Alzheimer disease dementia, and there is a pressing need for the development of assessment instruments that differentiate chronic cognitive impairment, acute neuropsychiatric symptomatology, and dementia in this population of patients. METHODS: We adapted a widely used instrument, the Clinical Dementia Rating (CDR) Scale, which is a component of the Uniform Data Set used by all federally funded Alzheimer Disease Centers for use in adults with DS, and tested the instrument among 34 DS patients recruited from the community. The participants were assessed using two versions of the modified CDR—a caregiver questionnaire and an in-person interview involving both the caregiver and the DS adult. Assessment also included the Dementia Scale for Down Syndrome (DSDS) and the Raven’s Progressive Matrices to estimate IQ. RESULTS: Both modified questionnaire and interview instruments captured a range of cognitive impairments, a majority of which were found to be chronic when accounting for premorbid function. Two individuals in the sample were strongly suspected to have early dementia, both of whom had elevated scores on the modified CDR instruments. Among individuals rated as having no dementia based on the DSDS, about half showed subthreshold impairments on the modified CDR instruments; there was substantial agreement between caregiver questionnaire screening and in-person interview of caregivers and DS adults. CONCLUSIONS: The modified questionnaire and interview instruments capture a range of impairment in DS adults, including subthreshold symptomatology, and the instruments provide complementary information relevant to the ascertainment of dementia in DS. Decline was seen across all cognitive domains and was generally positively related to age and negatively related to IQ. Most importantly, adjusting instrument scores for chronic, premorbid impairment drastically shifted the distribution toward lower (no impairment) scores. BioMed Central 2019-12-16 /pmc/articles/PMC6912998/ /pubmed/31842726 http://dx.doi.org/10.1186/s11689-019-9300-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lessov-Schlaggar, Christina N.
del Rosario, Olga L.
Morris, John C.
Ances, Beau M.
Schlaggar, Bradley L.
Constantino, John N.
Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title_full Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title_fullStr Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title_full_unstemmed Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title_short Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
title_sort adaptation of the clinical dementia rating scale for adults with down syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912998/
https://www.ncbi.nlm.nih.gov/pubmed/31842726
http://dx.doi.org/10.1186/s11689-019-9300-2
work_keys_str_mv AT lessovschlaggarchristinan adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome
AT delrosarioolgal adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome
AT morrisjohnc adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome
AT ancesbeaum adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome
AT schlaggarbradleyl adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome
AT constantinojohnn adaptationoftheclinicaldementiaratingscaleforadultswithdownsyndrome